Jacobs Levy Equity Management’s PTC Therapeutics PTCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Sell |
4,542
-31,527
| -87% | -$1.54M | ﹤0.01% | 972 |
|
|
2025
Q1 | $1.84M | Sell |
36,069
-790,450
| -96% | -$40.3M | 0.01% | 676 |
|
|
2024
Q4 | $37.3M | Sell |
826,519
-659,778
| -44% | -$29.8M | 0.13% | 156 |
|
|
2024
Q3 | $55.1M | Sell |
1,486,297
-229,494
| -13% | -$8.51M | 0.21% | 120 |
|
|
2024
Q2 | $52.5M | Buy |
1,715,791
+109,950
| +7% | +$3.36M | 0.22% | 108 |
|
|
2024
Q1 | $46.7M | Buy |
1,605,841
+282,422
| +21% | +$8.22M | 0.21% | 118 |
|
|
2023
Q4 | $36.5M | Buy |
1,323,419
+200,721
| +18% | +$5.53M | 0.18% | 128 |
|
|
2023
Q3 | $25.2M | Buy |
1,122,698
+104,024
| +10% | +$2.33M | 0.15% | 157 |
|
|
2023
Q2 | $41.4M | Buy |
1,018,674
+295,801
| +41% | +$12M | 0.24% | 106 |
|
|
2023
Q1 | $35M | Sell |
722,873
-158,483
| -18% | -$7.68M | 0.21% | 123 |
|
|
2022
Q4 | $33.6M | Buy |
881,356
+328,493
| +59% | +$12.5M | 0.23% | 132 |
|
|
2022
Q3 | $27.8M | Sell |
552,863
-269,231
| -33% | -$13.5M | 0.22% | 128 |
|
|
2022
Q2 | $32.9M | Buy |
822,094
+189,064
| +30% | +$7.57M | 0.25% | 109 |
|
|
2022
Q1 | $23.6M | Buy |
633,030
+53,814
| +9% | +$2.01M | 0.16% | 161 |
|
|
2021
Q4 | $23.1M | Buy |
579,216
+148,459
| +34% | +$5.91M | 0.15% | 157 |
|
|
2021
Q3 | $16M | Buy |
430,757
+2,584
| +0.6% | +$96.1K | 0.11% | 222 |
|
|
2021
Q2 | $18.1M | Buy |
428,173
+290,189
| +210% | +$12.3M | 0.12% | 208 |
|
|
2021
Q1 | $6.53M | Buy |
137,984
+92,099
| +201% | +$4.36M | 0.05% | 378 |
|
|
2020
Q4 | $2.8M | Sell |
45,885
-2,060
| -4% | -$126K | 0.02% | 507 |
|
|
2020
Q3 | $2.24M | Sell |
47,945
-4,451
| -8% | -$208K | 0.02% | 501 |
|
|
2020
Q2 | $2.66M | Buy |
52,396
+24,470
| +88% | +$1.24M | 0.03% | 467 |
|
|
2020
Q1 | $1.25M | Buy |
27,926
+21,616
| +343% | +$964K | 0.02% | 579 |
|
|
2019
Q4 | $303K | Sell |
6,310
-200
| -3% | -$9.6K | ﹤0.01% | 853 |
|
|
2019
Q3 | $220K | Buy |
6,510
+1,500
| +30% | +$50.7K | ﹤0.01% | 827 |
|
|
2019
Q2 | $225K | Buy |
+5,010
| New | +$225K | ﹤0.01% | 861 |
|
|
2018
Q4 | – | Sell |
-12,740
| Closed | -$599K | – | 1050 |
|
|
2018
Q3 | $599K | Sell |
12,740
-1,160
| -8% | -$54.5K | 0.01% | 741 |
|
|
2018
Q2 | $469K | Buy |
+13,900
| New | +$469K | 0.01% | 810 |
|
|
2018
Q1 | – | Sell |
-11,850
| Closed | -$198K | – | 1047 |
|
|
2017
Q4 | $198K | Buy |
+11,850
| New | +$198K | ﹤0.01% | 907 |
|
|
2017
Q2 | – | Sell |
-25,060
| Closed | -$247K | – | 1000 |
|
|
2017
Q1 | $247K | Sell |
25,060
-3,710
| -13% | -$36.6K | 0.01% | 757 |
|
|
2016
Q4 | $314K | Buy |
+28,770
| New | +$314K | 0.01% | 762 |
|